Mimicking SARS-CoV-2 nasal infection in monkeys

November 12, 2020

A new rhesus macaque animal model recapitulates the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) observed in humans by mimicking natural infection via the nasal route, according to a study published November 12 in the open-access journal PLOS Pathogens by Longding Liu, Qihan Li, Zhanlong He of the Chinese Academy of Medical Sciences & Peking Union Medical College, and colleagues. As noted by the authors, the new animal model could lead to effective treatments or vaccines for COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The first step of all effective means to control COVID-19 and develop vaccines is to understand the viral infection process. Toward that goal, an effective animal model of SARS-CoV-2 infection is urgently needed. In the new study, the researchers developed a rhesus macaque model to mimic natural infection via the nasal route. The rhesus macaques displayed similar clinical and pathological manifestations of COVID-19 observed in humans.

The results revealed SARS-CoV-2 virus shedding- the release of virus progeny following successful reproduction -- in the nose and stool for up to 27 days. This pattern of long-term viral shedding in rhesus macaques is strikingly similar to that observed in humans. The authors also observed similar pathological changes between humans and rhesus macaques in the progression from mild to marked interstitial pneumonia - an inflammatory condition affecting the tissue and space around the air sacs of the lungs. The results further revealed immune responses involving T cells, which contributed to the progression of COVID-19, and inflammation-promoting, cell-signaling molecules called inflammatory cytokines in the respiratory tract. The findings suggest that the development of COVID-19 treatments and vaccines should focus not only on viral shedding and interstitial pneumonia, but also T cell responses and cytokine changes in the lungs.

The authors conclude that their study of "nasal infection in rhesus monkey revealed the immune response and pathologic process of COVID-19".
-end-
Research Article

Funding:
The author(s) received no specific funding for this work.

Competing Interests:
The authors have declared that no competing interests exist.

Citation:
Zheng H, Li H, Guo L, Liang Y, Li J, Wang X, et al. (2020) Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression. PLoS Pathog 16(11): e1008949.
https://doi.org/10.1371/journal.ppat.1008949

Author Affiliations:
Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China

In your coverage please use this URL to provide access to the freely available paper:
http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008949

PLOS

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.